Skip to main content

Table 1 β-lactamase phenotypes encountered among the 912 strains analyzed

From: Analysis of β-lactamase phenotypes and carriage of selected β-lactamase genes among Escherichia coli strains obtained from Kenyan patients during an 18-year period

Antibiotics to which isolates were resistant

Penicillins, 1st & 2nd generation cephalosporins

3rd Generation cephalosporins & Monobactams

4th Generation cephalosporins

inhibitors

Cephamycins

Most probable Phenotypea

Total (%)n = 912

AMP, KF, AMX

NSBL

103 (11)

AMP, AMX, KF OXA

NSBL

175 (19)

AMP, AMX, KF OXA

AMC, AMS

IRT

65 (7)

AMP, KF, AMX,

AMC, AMS

IRT

8 (1)

AMP, AMX, KF, CXM

CTXb, AZTb

ESBL

105 (12)

AMP, AMX , KF, CXM

CTX, CAZ*, AZT

ESBL

75 (8)

AMP, AMX, OXA KF, CXM

CTXb, CAZb, AZT

FEP

AMS

ESBL

67 (7)

AMP, AMX, OXA KF, CXM

CTX, CAZ*, AZT

FEP

AMC, AMS

CMT

40 (4)

AMP, AMX, OXA, KF, CXM

CTX, CAZ, AZT

FEP

AMC, AMS, TZP

CMT

180 (20)

AMP, AMX, OXA KF, CXM

CTX, CAZ, AZT

FEP

AMC, AMS, TZP

FOX

pAmpC

94 (10)

  1. Resistance phenotypes of the 912 isolates investigated.
  2. a: β-lactamase phenotypes observed in different isolates were defined as follow:- Narrow spectrum β-lactamases (NSBLs) were resistant to penicillins but were susceptible to other classes of β-lactam antibiotics. Isolates exhibiting the inhibitor resistant TEM phenotype (IRT) were those capable of degrading penicillins, were not inhibited by β-lactamase inhibitors but were susceptible to other classes of β-lactam antibiotics. The ESBL-producers were resistant to penicillins, 2nd and most 3rd generation cephalosporins, and exhibited intermediate resistance to 4th generation cephalosporins and were fully susceptible to cephamycins, carbapenems and β-lactamase inhibitors. The complex mutant TEMs (CMTs) were resistant to most β-lactams and β-lactamase inhibitors including TZP but were susceptible to cephamycins and carbapenems. Isolates with the pAmpC phenotypes were resistant to all generations of β-lactam antibiotics, were susceptible to carbapenems and were either susceptible or exhibited intermediate resistance to 4th generation cephalosporins.
  3. b: appearance of zones of synergy between a given cephalosporin or monobactam and amoxicillin-clavulanic acid (AMC).
  4. (−) isolate with a given phenotype were susceptible to a given set of antibiotics.